ArticleBiomedical reports2026

Silencing of lncRNA TFAP2A-AS1 attenuates the development of acute coronary syndrome by inhibiting TFAP2A expression.

Shiwei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.